{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:50:56Z","timestamp":1791625856895,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470194"],"award-info":[{"award-number":["82470194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Medical Genetics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.gmg.2026.100140","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:52:45Z","timestamp":1790981565000},"page":"100140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epstein\u2013Barr virus-associated T\/NK-cell lymphoproliferative diseases with heterozygous IL10RA variants: two cases with pedigree analysis and a literature review"],"prefix":"10.1016","volume":"13","author":[{"given":"Yixin","family":"YAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"SONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"XIONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"YAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"ZHAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gmg.2026.100140_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gmg.2026.100140_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch."},{"issue":"5","key":"10.1016\/j.gmg.2026.100140_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","article-title":"Updated guidelines for chronic active Epstein-Barr virus disease","volume":"118","author":"Kawada","year":"2023","journal-title":"Int. J. Hematol."},{"issue":"6-7","key":"10.1016\/j.gmg.2026.100140_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00439-020-02145-3","article-title":"Genetic susceptibility to EBV infection: insights from inborn errors of immunity","volume":"139","author":"Tangye","year":"2020","journal-title":"Hum. Genet."},{"issue":"21","key":"10.1016\/j.gmg.2026.100140_bib5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2012.04.045","article-title":"Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy","volume":"143","author":"Kotlarz","year":"2012","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.gmg.2026.100140_bib7","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1182\/blood-2013-06-508267","article-title":"A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency","volume":"122","author":"Neven","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gmg.2026.100140_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1086\/322987","article-title":"Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism","volume":"184","author":"Helminen","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.gmg.2026.100140_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29097","article-title":"Polymorphisms and haplotypes of IL2RA, IL10, IFNG, IRF5, and CCR2 are associated with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children","volume":"68","author":"Tang","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.gmg.2026.100140_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41416-024-02893-3","article-title":"IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity","volume":"132","author":"Tai","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.gmg.2026.100140_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cei\/uxac040","article-title":"The clinical, molecular, and therapeutic features of patients with IL10\/IL10R deficiency: a systematic review","volume":"208","author":"Sharifinejad","year":"2022","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.gmg.2026.100140_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-026-09154-6","article-title":"A Comprehensive Review of IL-10 and IL-10 Receptor Deficiencies: From Basic Science to Clinical Bedside","volume":"69","author":"Xiao","year":"2026","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.gmg.2026.100140_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MIB.0000000000001058","article-title":"Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey","volume":"23","author":"Huang","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10875-022-01366-7","article-title":"Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications","volume":"43","author":"Aschenbrenner","year":"2023","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.gmg.2026.100140_bib15","doi-asserted-by":"crossref","first-page":"9606","DOI":"10.1038\/s41598-025-92979-6","article-title":"Treatment of IL-10RA deficiency of pediatric patients with very early onset inflammatory bowel disease by allogeneic haematopoietic stem cell transplantation","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.gmg.2026.100140_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ibd\/izy289","article-title":"Phenotypic characterization of very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency: based on a large cohort study","volume":"25","author":"Zheng","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.gmg.2026.100140_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/gene.2012.8","article-title":"Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease","volume":"13","author":"Mao","year":"2012","journal-title":"Genes. Immun."},{"issue":"3","key":"10.1016\/j.gmg.2026.100140_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.gmg.2026.100140_bib22","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/MPG.0000000000000532","article-title":"Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease","volume":"63","author":"Shouval","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/314883","article-title":"Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection","volume":"180","author":"Helminen","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1179\/1607845415Y.0000000040","article-title":"IL-10-592 A\/C polymorphisms is associated with EBV-HLH in Chinese children","volume":"21","author":"Wang","year":"2016","journal-title":"Hematology"},{"issue":"4960","key":"10.1016\/j.gmg.2026.100140_bib25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.2161559","article-title":"Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI","volume":"248","author":"Moore","year":"1990","journal-title":"Science"},{"issue":"4982","key":"10.1016\/j.gmg.2026.100140_bib26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.2173142","article-title":"Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1","volume":"250","author":"Hsu","year":"1990","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.158.2.604","article-title":"The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor","volume":"158","author":"Liu","year":"1997","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.178.2.439","article-title":"Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus","volume":"178","author":"Miyazaki","year":"1993","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.gmg.2026.100140_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/517260","article-title":"Viral interleukin-10 in chronic active Epstein-Barr virus infection","volume":"176","author":"Kanegane","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.gmg.2026.100140_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/mp.52.5.269","article-title":"Differential cytokine expression in EBV positive peripheral T cell lymphomas","volume":"52","author":"Ho","year":"1999","journal-title":"Mol. Pathol."},{"issue":"5","key":"10.1016\/j.gmg.2026.100140_bib31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0215(20010601)92:5<692::AID-IJC1237>3.0.CO;2-Z","article-title":"Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK\/T-cell lymphoma: Implications for tumor immune escape mechanism[J","volume":"92","author":"Shen","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.gmg.2026.100140_bib32","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2005-06-2569","article-title":"IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines","volume":"107","author":"Kis","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.gmg.2026.100140_bib33","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/ijc.22139","article-title":"Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3","volume":"119","author":"Takahara","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.gmg.2026.100140_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.2020005611","article-title":"Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells","volume":"137","author":"Collins","year":"2021","journal-title":"Blood"},{"issue":"57","key":"10.1016\/j.gmg.2026.100140_bib35","doi-asserted-by":"crossref","first-page":"31077","DOI":"10.18632\/oncotarget.25780","article-title":"STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target","volume":"9","author":"Onozawa","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.gmg.2026.100140_bib36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s12026-024-09531-3","article-title":"EBV\u2009+\u2009B cell-derived exosomes promote EBV-associated T\/NK-cell lymphoproliferative disease immune evasion by STAT3\/IL-10\/PD-L1 pathway","volume":"72","author":"Chen","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.gmg.2026.100140_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114696","article-title":"The lncRNA LINC02446 promotes tumor progression and HLH occurrence by regulating the expression of KLRs and IL-10 in EBV-NK-LPDs","volume":"156","author":"Ma","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.gmg.2026.100140_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat. Microbiol."}],"container-title":["Global Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940426000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940426000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:32:00Z","timestamp":1791624720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2699940426000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2699940426000482"],"URL":"https:\/\/doi.org\/10.1016\/j.gmg.2026.100140","relation":{},"ISSN":["2699-9404"],"issn-type":[{"value":"2699-9404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein\u2013Barr virus-associated T\/NK-cell lymphoproliferative diseases with heterozygous IL10RA variants: two cases with pedigree analysis and a literature review","name":"articletitle","label":"Article Title"},{"value":"Global Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gmg.2026.100140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100140"}}